血友病和肝病学,回到未来
Antonio Olveira1, Víctor Jiménez2
1Aparato Digestivo, Hospital Universitario La Paz, España.
Revista espanola de enfermedades digestivas
|March 7, 2024
概括
血友病患者历来因血液制品而面临严重的肝病. 从那时起,有效的乙型肝炎和型肝炎治疗已经大大减少了这种人群的肝脏并发症.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 病毒学 病毒学
背景情况:
- 从历史上看,血友病患者经历了严重的肝脏并发症,主要是肝硬化,这些并发症源于20世纪70年代和80年代使用的受污染的血源药物.
- 通过这些治疗获得的慢性乙型肝炎和型肝炎感染的长期后果几十年后表现出来,导致该队列中肝脏疾病的高负担.
研究的目的:
- 审查B型和C型肝炎对血友病患者的历史影响.
- 突出现代抗病毒疗法对血友病肝脏疾病管理的转化作用.
主要方法:
- 对患者结果的回顾性分析.
- 对血友病人群中乙型肝炎和C型肝炎患病率的流行病学数据的审查.
- 对抗病毒药物的治疗疗效的评估.
主要成果:
- 血源药物的广泛使用导致血友病患者中乙型肝炎和型肝炎感染的显著增加.
- 肝硬化和相关并发症的发展成为发病率和死亡率的主要原因.
- 引入恩特卡维尔,诺福维尔和直接作用的抗病毒药物彻底改变了治疗方法,导致持续的病毒清除和改善肝脏健康.
结论:
- 现代抗病毒疗法大大改善了病毒性肝炎的血友病患者的预后.
- 肝病诊所已经看到需要治疗肝病的血友病患者显著减少,这意味着临床的重大进展.
相关概念视频
Disorders of Hemostasis
904
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
904
Anticoagulant Drugs: Low-Molecular-Weight Heparins
696
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Blood Transfusion
559
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
559
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Rh Blood Group
1.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.5K


